A Message from Our CEO in Advance of Rare Disease Day
Paul Perreault, CSL Limited CEO and Managing Director
I’d like to share a message that I sent to all employees as we prepare to celebrate Rare Disease Day on February 28. It’s a day that means a lot to me and our employees around the globe.
At the end of this month, the rare disease community will once again join together to recognize Rare Disease Day. It’s a day, above all, that represents connection and hope.
We’re all connected as patients, caregivers, doctors, health care workers, scientists in the lab, plasma donors and those who produce life-changing medicines. Our collective hope shines light on all the progress we’ve made and the challenges still before us to overcome. Too few patients receive a swift and accurate diagnosis and many more need access to treatments that can improve the quality of their lives. And the medicines we call best-in-class today must continue to evolve and improve.
On February 28th, as night falls across the continents, famous landmarks will light up in the bright colors of Rare Disease Day. These illuminations around the world remind us of what the rare disease community stands for and how the need to innovate never ends.
Throughout February, CSL will recognize rare diseases through a number of upcoming communications and engagements. At this special time of year, I ask our colleagues to reflect on the promise we have made to patients. And though Rare Disease Day is just one day on the calendar, let’s recommit ourselves to deliver on that promise 365 days a year.
" Our collective hope shines a light on progress made and challenges ahead,” CSL Limited CEO Paul Perreault said in a video message to 25,000 employees. "Paul Perreault, CSL Limited CEO and Managing Director